Literature DB >> 23913897

Paternal involvement and fetal morbidity outcomes in HIV/AIDS: a population-based study.

Amina P Alio1, Alfred K Mbah2, Krupa Shah1, Euna M August2, Sharon Dejoy2, Korede Adegoke2, Phillip J Marty2, Hamisu M Salihu3, Muktar H Aliyu4.   

Abstract

Prior research indicates that infants with absent fathers are vulnerable to unfavorable fetal birth outcomes. HIV is a recognized risk factor for adverse birth outcomes. However, the influence of paternal involvement on fetal morbidity outcomes in women with HIV remains poorly understood. Using linked hospital discharge data and vital statistics records for the state of Florida (1998-2007), the authors assessed the association between paternal involvement and fetal growth outcomes (i.e., low birth weight [LBW], very low birth weight [VLBW], preterm birth [PTB], very preterm birth [VPTB], and small for gestational age [SGA]) among HIV-positive mothers (N=4,719). Propensity score matching was used to match cases (absent fathers) to controls (fathers involved). Conditional logistic regression was employed to generate adjusted odds ratios (OR). Mothers of infants with absent fathers were more likely to be Black, younger (<35 years old), and unmarried with at least a high school education (p<.01). They were also more likely to have a history of drug (p<.01) and alcohol (p=.02) abuse. These differences disappeared after propensity score matching. Infants of HIV-positive mothers with absent paternal involvement during pregnancy had elevated risks for adverse fetal outcomes (LBW: OR=1.30, 95% confidence interval [CI]=1.05-1.60; VLBW: OR=1.72, 95% CI=1.05-2.82; PTB: OR=1.38, 95% CI=1.13-1.69; VPTB: OR=1.81, 95% CI=1.13-2.90). Absence of fathers increases the likelihood of adverse fetal morbidity outcomes in women with HIV infection. These findings underscore the importance of paternal involvement during pregnancy, especially as an important component of programs for prevention of mother-to-child transmission of HIV.
© The Author(s) 2013.

Entities:  

Keywords:  HIV/AIDS; parenting; population based; public health

Mesh:

Year:  2013        PMID: 23913897      PMCID: PMC3909720          DOI: 10.1177/1557988313498890

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  37 in total

1.  Acceptability and feasibility of infant-feeding options: experiences of HIV-infected mothers in the World Health Organization Kesho Bora mother-to-child transmission prevention (PMTCT) trial in Burkina Faso.

Authors:  Cécile Cames; Aisha Saher; Kossiwavi A Ayassou; Amandine Cournil; Nicolas Meda; Kirsten Bork Simondon
Journal:  Matern Child Nutr       Date:  2010-07-01       Impact factor: 3.092

2.  Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.

Authors:  J S Lambert; D H Watts; L Mofenson; E R Stiehm; D R Harris; J Bethel; J Whitehouse; E Jimenez; J Gandia; G Scott; M J O'Sullivan; A Kovacs; A Stek; W T Shearer; H Hammill; R van Dyke; R Maupin; M Silio; M G Fowler
Journal:  AIDS       Date:  2000-07-07       Impact factor: 4.177

3.  Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.

Authors:  C Rudin; A Spaenhauer; O Keiser; M Rickenbach; C Kind; K Aebi-Popp; M W G Brinkhof
Journal:  HIV Med       Date:  2010-08-18       Impact factor: 3.180

4.  Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

Authors:  Maria C Marazzi; Leonardo Palombi; Karin Nielsen-Saines; Jere Haswell; Ines Zimba; Nurja A Magid; Ersilia Buonomo; Paola Scarcella; Susanna Ceffa; Giovanna Paturzo; Pasquale Narciso; Giuseppe Liotta
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

5.  Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Authors:  Katherine M Knapp; Susan B Brogly; Daniel G Muenz; Hans M L Spiegel; Daniel H Conway; Gwendolyn B Scott; Jeffrey T Talbot; David E Shapiro; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2012-02       Impact factor: 2.129

6.  Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Authors:  Sandra Hernàndez; Constanza Morén; Marta López; Oriol Coll; Francesc Cardellach; Eduard Gratacós; Oscar Miró; Glòria Garrabou
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

7.  Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors.

Authors:  J R Ickovics; K A Ethier; L J Koenig; T E Wilson; E B Walter; M I Fernandez
Journal:  Health Psychol       Date:  2000-11       Impact factor: 4.267

8.  The impact of paternal involvement on feto-infant morbidity among Whites, Blacks and Hispanics.

Authors:  Amina P Alio; Jennifer L Kornosky; Alfred K Mbah; Phillip J Marty; Hamisu M Salihu
Journal:  Matern Child Health J       Date:  2009-06-13

9.  The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Agnes Chidanyika; Tsungai Chipato; Shabbar Jaffar; Nancy Padian
Journal:  AIDS Behav       Date:  2011-07

10.  Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa.

Authors:  James Ndirangu; Marie-Louise Newell; Ruth M Bland; Claire Thorne
Journal:  Hum Reprod       Date:  2012-03-21       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.